Biote Corp (BTMD)
5.84
+0.01
(+0.17%)
USD |
NASDAQ |
May 16, 16:00
5.80
-0.04
(-0.68%)
After-Hours: 20:00
Biote Shareholders Equity (Quarterly): -35.40M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -35.40M |
| December 31, 2023 | -29.40M |
| September 30, 2023 | -40.53M |
| June 30, 2023 | -46.40M |
| March 31, 2023 | -48.54M |
| Date | Value |
|---|---|
| December 31, 2022 | -44.46M |
| September 30, 2022 | -37.18M |
| June 30, 2022 | -24.95M |
| December 31, 2021 | 4.125M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-48.54M
Minimum
Mar 2023
4.125M
Maximum
Dec 2021
-33.64M
Average
-37.18M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| Teladoc Health Inc | 2.289B |
| American Shared Hospital Services | 22.62M |
| Novo Integrated Sciences Inc | 22.19M |
| Astrana Health Inc | 653.49M |
| Cryo-Cell International Inc | -10.34M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 160.11M |
| Total Liabilities (Quarterly) | 205.01M |
| Debt to Equity Ratio | -3.150 |
| Current Ratio | 4.754 |
| Net Debt Paydown Yield | 0.69% |